GeneDx Holdings (WGS) Asset Writedowns and Impairment (2021 - 2026)
GeneDx Holdings (WGS) reported Asset Writedowns and Impairment of $31.3 million for Q1 2026, up 20683.55% quarter-over-quarter from -$152000.0 in Q4 2025.
GeneDx Holdings (WGS) Asset Writedowns and Impairment (2021 - 2026) Analysis & Trends
GeneDx Holdings (WGS) has 6 years of Asset Writedowns and Impairment data on file, last reported at $31.3 million in Q1 2026.
- Asset Writedowns and Impairment for Q1 2026 came in at $31.3 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $31.3 million (up 22937.23% YoY), and the FY2023 annual result was $3.9 million, up 247.82% from the prior year.
- Asset Writedowns and Impairment improved to $31.3 million in Q1 2026 per WGS's latest filing, from -$152000.0 in the prior quarter.
- Over five years, Asset Writedowns and Impairment peaked at $174.5 million in Q4 2022 and troughed at -$152000.0 in Q4 2025.
- A 5-year average of $19.7 million and a median of $123000.0 in 2025 frame the typical range for Asset Writedowns and Impairment.
- The sharpest annual moves came in 2022 and 2024: Asset Writedowns and Impairment surged 15652.58% in 2022, then sank 149.1% in 2024.
- A 5-year view of Asset Writedowns and Impairment shows it stood at $174.5 million in 2022, then slumped by 99.84% to $279000.0 in 2023, then slumped by 149.1% to -$137000.0 in 2024, then slipped by 10.95% to -$152000.0 in 2025, then soared by 20683.55% to $31.3 million in 2026.
- Business Quant data shows WGS's Asset Writedowns and Impairment at $31.3 million in Q1 2026, -$152000.0 in Q4 2025, and $29000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn |
| 10 | GeneDx Holdings | 1.65 Bn | 1.48 Bn | 68.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31.29 Mn |
| Mar 31, 2026 | 31.29 Mn |
| Dec 31, 2025 | -152,000.00 |
| Dec 31, 2025 | -152,000.00 |
| Sep 30, 2025 | 29,000.00 |
| Sep 30, 2025 | 29,000.00 |
| Jun 30, 2025 | 123,000.00 |
| Jun 30, 2025 | 123,000.00 |
| Dec 31, 2024 | -137,000.00 |
| Dec 31, 2024 | -137,000.00 |
| Mar 31, 2024 | 40,000.00 |
| Mar 31, 2024 | 40,000.00 |
| Dec 31, 2023 | 279,000.00 |
| Dec 31, 2023 | 279,000.00 |
| Sep 30, 2023 | 8.28 Mn |
| Sep 30, 2023 | 8.28 Mn |
| Mar 31, 2023 | 2.12 Mn |
| Mar 31, 2023 | 2.12 Mn |
| Dec 31, 2022 | 174.50 Mn |
| Dec 31, 2022 | 174.50 Mn |